Adipose tissue-derived mesenchymal stem cell therapy (AD-MSC)

· Vinmec Research Institute of Stem Cell and Gene Technology

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Adipose tissue-derived mesenchymal stem cell therapy (AD-MSC), covering 2024-06-04 to 2024-06-04. Get the full timeline:

Most recent: Clinical Trial Update: Adipose Tissue-derived Mesenchymal Stem Cell (AD-MSC) Therapy for the Treatment of Sexual Function Impairment in Female [Phase 2]

See pricing